Atlas Trials

Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma

Clinical trial NCT01869023 · UNKNOWN

Trial details

NCT number
NCT01869023
Sponsor
Instituto Nacional de Cancerologia de Mexico
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Malignant Pleural Mesothelioma
Start date
2010-11-01
Primary completion
2017-12-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.